Amgen Inc., et al v. Robert Kennedy, Jr., et al
| UCB, Inc., Eli Lilly and Company and Amgen Inc. |
| Health Resources and Services Administration, United States Department of Health and Human Services, Carole Johnson, in her official capacity, Thomas J. Engels, in his official capacity and Robert F. Kennedy, Jr., in his official capacity |
| 26-5376 |
| October 29, 2026 |
| U.S. Court of Appeals, D.C. Circuit |
| Other Statutes APA/Review Agency |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 30, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| CLERK'S ORDER [2201085] filed consolidating cases 26-5375 and 26-5376 (Cross-appeal started 10/30/2026) with 26-5357. Cross-appellants in case No.(s) 26-5375 and 26-5376 are directed to comply with the deadlines set in the order [ # 2198186-2 ]. [26-5357, 26-5359, 26-5375, 26-5376] [Entered: 10/30/2026 12:24 PM] |
| US CIVIL CASE docketed. [26-5376] [Entered: 10/29/2026 09:32 AM] |
| NOTICE OF APPEAL [2200825] seeking review of a decision by the U.S. District Court in 1:24-cv-03571-JEB filed by Health Resources and Services Administration, Carole Johnson, Robert F. Kennedy, Jr. and HHS. Appeal assigned USCA Case Number: 26-5376. [26-5376] [Entered: 10/29/2026 09:59 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
